S
PTGX icon

SignatureFD’s Protagonist Therapeutics PTGX Stock Holding History

SignatureFD’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5K Buy
322
+34
+12% +$3.55K ﹤0.01% 2011
2026
Q1 		$30.4K Buy
288
+125
+77% +$11.1K ﹤0.01% 2008
2025
Q4 		$14.2K Buy
163
+14
+9% +$1.15K ﹤0.01% 2262
2025
Q3 		$9.9K Hold
149
– – ﹤0.01% 2408
2025
Q2 		$8.23K Buy
149
+55
+59% +$2.64K ﹤0.01% 2420
2025
Q1 		$4.55K Buy
+94
New +$3.94K ﹤0.01% 2638
2024
Q4 		– Sell
-20
Closed -$900 – 3379
2024
Q3 		$900 Buy
+20
New +$808 ﹤0.01% 3018
2023
Q3 		– Sell
-33
Closed -$911 – 3282
2023
Q2 		$911 Buy
+33
New +$826 ﹤0.01% 2992
2022
Q2 		– Sell
-78
Closed -$2K – 3298
2022
Q1 		$2K Buy
78
+32
+70% +$902 ﹤0.01% 2840
2021
Q4 		$2K Hold
46
– – ﹤0.01% 2778
2021
Q3 		$1K Hold
46
– – ﹤0.01% 2894
2021
Q2 		$2K Hold
46
– – ﹤0.01% 2610
2021
Q1 		$1K Hold
46
– – ﹤0.01% 2666
2020
Q4 		$1K Hold
46
– – ﹤0.01% 2471
2020
Q3 		$1K Buy
+46
New +$863 ﹤0.01% 2477

Other funds holding PTGX

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

SignatureFD's PTGX Position: Q2 2026 in Review

SignatureFD increased its Protagonist Therapeutics (PTGX) stake by 12% in Q2 2026, buying an estimated $3.55K and bringing the position to 322 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

SignatureFD first reported a position in PTGX in Q3 2020 and has held it in 15 quarters since. 45 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • SignatureFD held 322 shares of Protagonist Therapeutics worth $39.5K as of Q2 2026.
  • SignatureFD bought 34 Protagonist Therapeutics shares in Q2 2026, an estimated $3.55K.
  • Protagonist Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2011 holding.
  • SignatureFD first reported a position in Protagonist Therapeutics in Q3 2020 and has held it in 15 quarters since.
  • 45 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.